7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Evaxion Biotech A/S
(NASDAQ:EVAX) 

EVAX stock logo

Evaxion Biotech A/S, a clinical-stage artificial intelligence-immunology platform company, identifies and develops novel immunotherapies for the treatment of various cancers, bacterial diseases, and viral infections. The company develops therapies using PIONEER, an immuno-oncology platform; EDEN, a ...

Founded: 2008
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Evaxion Biotech A/S Op Cashflow Per Share ttm
202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 -1.13-0.0612.073.134.25.266.32
Evaxion Biotech A/S Free Cashflow Per Share ttm
202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 -1.18-0.081.012.113.24.295.396.48
Evaxion Biotech A/S Cash Per Share ttm
202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 00.190.390.580.770.971.161.36
Evaxion Biotech A/S (GAAP) P/E ratio ttm
202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 -2.72-2.33-1.94-1.55-1.17-0.78-0.390
Evaxion Biotech A/S P/B ratio ttm
202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 -0.481.323.134.946.758.5510.3612.17
No extra charts and metrics for this ticker.